1. Home
  2. WVE vs MAG Comparison

WVE vs MAG Comparison

Compare WVE & MAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • MAG
  • Stock Information
  • Founded
  • WVE 2012
  • MAG N/A
  • Country
  • WVE Singapore
  • MAG Canada
  • Employees
  • WVE N/A
  • MAG N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • MAG Precious Metals
  • Sector
  • WVE Health Care
  • MAG Basic Materials
  • Exchange
  • WVE Nasdaq
  • MAG Nasdaq
  • Market Cap
  • WVE 939.3M
  • MAG 1.6B
  • IPO Year
  • WVE 2015
  • MAG N/A
  • Fundamental
  • Price
  • WVE $6.54
  • MAG $15.96
  • Analyst Decision
  • WVE Strong Buy
  • MAG Strong Buy
  • Analyst Count
  • WVE 11
  • MAG 4
  • Target Price
  • WVE $20.91
  • MAG $19.25
  • AVG Volume (30 Days)
  • WVE 1.7M
  • MAG 635.8K
  • Earning Date
  • WVE 05-08-2025
  • MAG 05-20-2025
  • Dividend Yield
  • WVE N/A
  • MAG 1.13%
  • EPS Growth
  • WVE N/A
  • MAG 59.57
  • EPS
  • WVE N/A
  • MAG 0.88
  • Revenue
  • WVE $104,939,000.00
  • MAG N/A
  • Revenue This Year
  • WVE N/A
  • MAG N/A
  • Revenue Next Year
  • WVE N/A
  • MAG N/A
  • P/E Ratio
  • WVE N/A
  • MAG $18.18
  • Revenue Growth
  • WVE N/A
  • MAG N/A
  • 52 Week Low
  • WVE $4.25
  • MAG $11.29
  • 52 Week High
  • WVE $16.74
  • MAG $18.27
  • Technical
  • Relative Strength Index (RSI)
  • WVE 42.23
  • MAG 55.75
  • Support Level
  • WVE $6.30
  • MAG $14.47
  • Resistance Level
  • WVE $8.39
  • MAG $15.64
  • Average True Range (ATR)
  • WVE 0.66
  • MAG 0.62
  • MACD
  • WVE 0.10
  • MAG 0.05
  • Stochastic Oscillator
  • WVE 33.21
  • MAG 86.63

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MAG MAG Silver Corporation

MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.

Share on Social Networks: